An effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systems
Metadatos
Afficher la notice complèteAuteur
Cano Cortes, María Victoria; Altea-Manzano, Patricia; Laz Ruiz, José Antonio; Unciti Broceta, Juan Diego; López Delgado, Francisco Javier; Espejo Román, José Manuel; Díaz Mochón, Juan José; Sánchez Martín, Rosario MaríaEditorial
Royal Society Chemistry
Date
2021-02-14Referencia bibliográfica
Cano-Cortes, M. V., Altea-Manzano, P., Laz-Ruiz, J. A., Unciti-Broceta, J. D., Lopez-Delgado, F. J., Espejo-Roman, J. M., ... & Sanchez-Martin, R. M. (2021). An effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systems. Nanoscale, 13(6), 3500-3511. [DOI: 10.1039/d0nr07145e]
Patrocinador
Health Institute Carlos III (ISCIII) DTS18/00121; Junta de Andalucia-FEDER, Ministry of Economy, Knowledge, Companies and University (University of Granada) B-FQM-475-UGR18 PT18-TP-1490 AT17_6096- OTRI; Spanish State Research Agency RED2018-102469-T; Fundación Benéfica Anticáncer San Francisco Javier y Santa Cándida; Spanish Ministry of Economy and Competitiveness PTQ-16- 08597; Spanish Government FPU 16/02061Résumé
In this manuscript, we report the development of a versatile,
robust, and stable targeting nanocarrier for active delivery. This
nanocarrier is based on bifunctionalized polymeric nanoparticles
conjugated to a monoclonal antibody that allows for active targeting
of either (i) a fluorophore for tracking or (ii) a drug for monitoring
specific cell responses. This nanodevice can efficiently discriminate
between cells in coculture based on the expression
levels of cell surface receptors. As a proof of concept, we have
demonstrated efficient delivery using a broadly established cell
surface receptor as the target, the epidermal growth factor receptor
(EGFR), which is overexpressed in several types of cancers.
Additionally, a second validation of this nanodevice was successfully
carried out using another cell surface receptor as the target,
the cluster of differentiation 147 (CD147). Our results suggest that
this versatile nanocarrier can be expanded to other cell receptors
and bioactive cargoes, offering remarkable discrimination
efficiency between cells with different expression levels of a
specific marker. This work supports the ability of nanoplatforms to
boost and improve the progress towards personalized medicine.